Biomarker Could Better Predict Response to Immunotherapy in Black Patients with Skin Cancer
University Hospital Bonn
The new biomarker could predict who may be resistant or develop resistance to melanoma treatment
Melanoma
FDA Approves First Immunotherapy for Metastatic Skin Cancer
U.S. Food and Drug Administration
The FDA granted the approval of Amtagvi to Iovance Biotherapeutics Inc.
Neoadjuvant Shows Positive Response in Advanced Melanoma Trial
SWOG Cancer Research Network
Single-agent immunotherapy shrinks over half of advanced melanomas when given before surgery
Biomarkers That Predict Response to Immune Checkpoint Inhibitor Therapy
The Wistar Institute
New research finds biological processes that improve prediction of therapeutic performance
Biomarkers to Predict Patient Response to Immunotherapy Treatment for Melanoma
Wake Forest Baptist Medical Center
New study finds blood biomarkers that help indicate the effectiveness of immune checkpoint inhibitors
First Melanoma Test to Reliably Predict Risk of Cancer Spread
Newcastle University
New test developed as mechanism of skin cancer growth understood
Researchers Uncover Insights into How Moles Change into Melanoma
Huntsman Cancer Institute
Gene-Based Blood Test for Melanoma Spread Evaluates Treatment Progress
NYU Langone Health
The test monitors blood levels of DNA fragments released by dying tumor cells as an early indicator of treatment success
Sensitizing 'Cold' Melanomas to Immunotherapies
American Association for Cancer Research
Approximately 40 percent of melanomas lack sufficient infiltration of immune cells within the tumor and therefore have poor responses to immunotherapies
Missing BAP1 Gene Associated with Immunosuppressive Molecules in Uveal Melanoma
University of Turku
Study suggests implications for immunotherapy development